share_log

Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $75

Benzinga ·  May 6 08:58

Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $67 to $75.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment